Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check2 days agoChange DetectedThe completed remdesivir COVID-19 trial record is displayed, with its study design, eligibility criteria, outcomes, locations, publications, and supporting documents.SummaryDifference100%

- Check9 days agoChange DetectedThe study record area now displays a 403 Forbidden message and a Home button. The site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.8%

- Check23 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 while the study record page continued to display a 403 error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check51 days agoChange DetectedThe Study record page now displays a 403 Forbidden error instead of the expected content, blocking access to the NCT04292899 study details. The page loads an error screen rather than showing the study information and related documents.SummaryDifference17%

- Check58 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating an updated page version.SummaryDifference0.0%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.